These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


190 related items for PubMed ID: 9182654

  • 1. Drug therapy of severe hypercholesterolemia.
    Weizel A, Richter WO.
    Eur J Med Res; 1997 Jun 16; 2(6):265-9. PubMed ID: 9182654
    [Abstract] [Full Text] [Related]

  • 2. [Drug therapy of hypercholesterolemia].
    Schwandt P, Richter WO.
    Wien Klin Wochenschr; 1995 Jun 16; 107(18):544-8. PubMed ID: 7483641
    [Abstract] [Full Text] [Related]

  • 3. [Therapy of dyslipidemia in post-infarction: state of the art].
    Borgia MC, Nardi M, Da Ros S, Castellano V.
    Clin Ter; 2007 Jun 16; 158(6):523-32. PubMed ID: 18265719
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Hyperlipidemia: therapeutic principles in clinical practice].
    Müller-Wieland D, Krone W.
    Med Klin (Munich); 2003 Dec 15; 98(12):739-43. PubMed ID: 14685674
    [Abstract] [Full Text] [Related]

  • 6. Effects of nicotinic acid and lovastatin in combination with cholestyramine in renal transplant patients.
    Lal SM, Katyal A.
    Mo Med; 2002 Dec 15; 99(10):580-4. PubMed ID: 12534147
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS, Bacon SP, Illingworth DR.
    J Lab Clin Med; 2003 Apr 15; 141(4):250-6. PubMed ID: 12677170
    [Abstract] [Full Text] [Related]

  • 10. HMG-CoA reductase inhibitors: a look back and a look ahead.
    Davignon J, Montigny M, Dufour R.
    Can J Cardiol; 1992 Oct 15; 8(8):843-64. PubMed ID: 1423005
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [LDL cholesterol--why lower and lower?].
    Müller-Wieland D, Kotzka J.
    MMW Fortschr Med; 2007 May 31; 149(22):28-30. PubMed ID: 18069223
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Utility of currently available modes of therapy in reaching lipid goals.
    Spratt KA, Denke MA.
    J Am Osteopath Assoc; 2004 Sep 31; 104(9 Suppl 7):S14-6. PubMed ID: 15467019
    [Abstract] [Full Text] [Related]

  • 16. [The role of cholesterol-lowering drugs in prevention of coronary heart disease].
    Skałuba Z, Undas R.
    Przegl Lek; 1998 Sep 31; 55(7-8):382-7. PubMed ID: 10021881
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.